SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,469,000 | -12.5% | 15,016 | +35.9% | 1.61% | +76.8% |
| Q2 2019 | $1,679,000 | -28.3% | 11,050 | -23.8% | 0.91% | -58.0% |
| Q3 2018 | $2,343,000 | +57.6% | 14,508 | +29.0% | 2.16% | +48.1% |
| Q2 2018 | $1,487,000 | -31.1% | 11,249 | -61.4% | 1.46% | -45.8% |
| Q1 2018 | $2,158,000 | -10.0% | 29,133 | -32.4% | 2.70% | -17.1% |
| Q4 2017 | $2,399,000 | -49.7% | 43,125 | -59.0% | 3.26% | -41.1% |
| Q3 2017 | $4,766,000 | -11.0% | 105,066 | -33.8% | 5.53% | -12.9% |
| Q2 2017 | $5,353,000 | +107.4% | 158,810 | +82.2% | 6.35% | +76.4% |
| Q1 2017 | $2,581,000 | – | 87,180 | – | 3.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |